Common eye conditions are linked to increased risks for incident attention-deficit/hyperactivity disorder, particularly in women and in the pediatric population, a retrospective study shows. Medscape Medical News
In Editorial, The New England Journal of Medicine Calls Science Corporation's PRIMA Implant "The First Treatment to Restore Vision" In Patients Suffering From Advanced Geographic Atrophy Due to Age-related Macular Degeneration
ALAMEDA, Calif.–(BUSINESS WIRE)–An editorial published today in The New England Journal of Medicine (NEJM) writes that Science Corporation’s PRIMA implant is the first treatment in clinical trials to successfully restore functional vision to certain …
Advice on Recognizing and Managing Sjӧgren Disease
Dr Nancy Carteron urges clinicians to learn to recognize how Sjӧgren disease could be hiding in plain sight and why early care is more essential than ever. Medscape
Uncategorized
PopHIVE is ‘democratizing the data’ in public health
Yale School of Public Health recently unveiled a platform that offers reliable, real-time, synthesized health data directly to the public, providing a more complete picture for health care providers and public health experts.PopHIVE — Population Health…
When Eye Problems Signal a Wider Immune Issue and Vice Versa
Patients with immune-mediated diseases face a high risk for incident uveitis, and those with uveitis face a high risk of developing or already having an immune-mediated disease, a recent study shows. Medscape Medical News
Uncategorized
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced its prelimina…